Axial3D receives FDA clearance for artificial intelligence-driven segmentation platform
Click Here to Manage Email Alerts
Key takeaways:
- Axial3D has announced FDA clearance of its automated medical segmentation platform.
- Axial3D also received investment funding from Stratasys.
Axial3D announced it received FDA clearance of its artificial intelligence-driven, automated medical segmentation platform for orthopedic trauma, orthopedic, maxillofacial and cardiovascular applications, according to a press release.
“Our FDA clearance for Axial3D Insight is a testament to how far Axial3D has come,” Daniel Crawford, founder and chief strategy office of Axial3D, said in the release. “From our humble beginnings as a startup to now being recognized as a leading medical technology company, this achievement showcases our dedication to pushing the boundaries of innovation in health care. We are immensely proud of our team’s commitment in delivering exceptional patient care using advanced automation, artificial intelligence and machine learning technologies.”
Used in conjunction with Stratasys print technology, the release noted Axial3D Insight automates the conversion process of 2D Digital Imaging and Communications in Medicine images, such as CT and MRI scans, into accurate 3D visualizations, 3D print-ready files, 3D mesh files or 3D-printed anatomical models. The platform allows surgeons to improve their diagnostic accuracy, preoperative planning and surgical intervention. Medical device companies can also use the platform to accelerate patient-specific programs by processing more patient data with the same resources, which can be used to design personalized devices and surgical kits, according to the release.
“Stratasys is proud to partner with Axial3D in driving innovation and in transforming the health care landscape with 3D solutions that help make personalized health care at scale possible,” Yoav Zeif, CEO of Stratasys, said in the release. “We congratulate Axial3D on achieving FDA clearance for their segmentation platform, leveraging the power of automation and [artificial intelligence] AI as a key business driver for their continued success in the medical sector.”
Read more about
Click Here to Manage Email Alerts